Table 3 Characteristics of respiratory infections according to common seasonal respiratory virus (CSRV) type and periods.
PCR+= 300 peisodes N° total CSRV isolated = 355a | Type of CSRV | ||||||||
---|---|---|---|---|---|---|---|---|---|
Ev/Rh | hMPV | ADV | HBoV | RSV | hIV | HPIV | HCoV | SARS-CoV-2 | |
P1 (N° total CSRV isolated = 140) | |||||||||
Number of Episodes, n (%) | 50 (14.1) | 16 (4.5) | 2 (0.6) | 6 (1.7) | 19 (5.4) | 23 (6.5) | 22 (6.2) | 2 (0.6) | 0 (0) |
URTD, n (%) | 48 (96) | 15 (93.8) | 2 (100) | 6 (100) | 18 (94.7) | 22 (95.7) | 22 (100) | 2 (100) | 0 (0) |
LRTD, n (%) | 22 (44) | 8 (50) | 1 (50) | 2 (33.3) | 11 (57.9) | 16 (69.6) | 8 (36.4) | 1 (50) | 0 (0) |
CARV Co-infection, n (%) | 8 (16) | 4 (25) | 1 (50) | 5 (83.3) | 12 (63.2) | 12 (52.2) | 6 (27.3) | 0 (0) | 0 (0) |
Hospitalization, n (%) | 17 (34) | 2 (12.5) | 1 (50) | 2 (33.3) | 10 (52.6) | 11 (47.8) | 6 (27.3) | 1 (50) | 0 (0) |
Day-90 all-cause mortality | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (5.3) | 0 (0) | 1 (4.5) | 0 (0) | 0 (0) |
P2 (N° total CSRV isolated = 171) | |||||||||
Number of Episodes, n (%) | 61 (17,2) | 3 (0.8) | 7 (2) | 2 (0.6) | 11 (3.1) | 27 (7.6) | 32 (9) | 28 (7.9) | 0 (0) |
URTD, n (%) | 60 (98.4) | 3 (100) | 7 (100) | 2 (100) | 11 (100) | 26 (96.3) | 32 (100) | 28 (100) | 0 (0) |
LRTD, n (%) | 13 (21.3) | 1 (33.3) | 2 (28.6) | 1 (50) | 5 (45.5) | 9 (33.4) | 11 (31.4) | 8 (28.6) | 0 (0) |
CARV Co-infection, n (%) | 15 (24.6) | 0 (0) | 3 (42.9) | 1 (50) | 4 (36.4) | 5 (18.6) | 11 (31.4) | 10 (35.7) | 0 (0) |
Hospitalization, n (%) | 15 (24.6) | 0 (0) | 1 (14.3) | 1 (50) | 2 (18.2) | 4 (14.8) | 9 (28.1) | 8 (28.6) | 0 (0) |
Day-90 all-cause mortality | 1 (1.6) | 0 (0) | 1 (14.3) | 0 (0) | 1 (9.1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
P3 (N° total CSRV isolated = 44) | |||||||||
Number of Episodes, n (%) | 11 (3.1) | 3 (0.8) | 1 (0.3) | 0 (0) | 1 (0.3) | 5 (1.4) | 1 (0.3) | 13 (3.7) | 9 (2.6) |
URTD, n (%) | 8 (72.7) | 3 (100) | 1 (100) | 0 (0) | 1 (100) | 5 (100) | 1 (100) | 13 (100) | 5 (55.6) |
LRTD, n (%) | 5 (45.5) | 2 (66.7) | 0 (0) | 0 (0) | 0 (0) | 2 (40) | 0 (0) | 1 (7.7) | 5 (55.6) |
CSRV Co-infection, n (%) | 0 (0) | 1 (33.3) | 1 (100) | 0 (0) | 0 (0) | 1 (20) | 1 (100) | 1 (7.7) | 0 (0) |
Hospitalization, n (%) | 3 (27.3) | 2 (66.7) | 0 (0) | 0 (0) | 0 (0) | 1 (20) | 0 (0) | 0 (0) | 4 (44.4) |
Day-90 all-cause mortality | 1 (9.1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (7.1) | 3 (33.3) |